Responses
Regular and young investigator award abstracts
Immune-stimulants and immune modulators
590 Pre-conditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.